Objective To describe the clinical, laboratory, and radiographic manifestations of Takayasu
arteritis (TA) in a cohort from the US, evaluate the response to interventions, remission and …

Objectives To assess the efficacy of tocilizumab in patients with Takayasu arteritis (TA).
Methods We conducted a retrospective multicenter study in 46 TA patients treated with …

Purpose: Takayasu's arteritis (TAK) is a large-vessel vasculitis. Glucocorticoids (GCs)
combined with cyclophosphamide (CTX) is a common treatment option, but their efficacy is …

SIR, Takayasu arteritis (TA) is a chronic inflammatory arteritis affecting predominantly the
aorta and its main branches, leading to wall thickening, followed by stenosis [1]. Only half of …

Recent studies suggested that anti-TNF-α biological therapies are effective in treating
Takayasu's arteritis (TA) refractory to conventional immunosuppressive therapy. However …

Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to
conventional immunosuppressive treatment. However, some patients fail to respond even to …

Takayasu arteritis (TAK) is a systemic granulomatous large-vessel vasculitis with a
phenotype that overlaps with GCA and defined by the 1993 and 2012 Chapel Hill …

We have read with interest the article by Nakaoka and colleagues 1 on the efficacy and
safety of tocilizumab in patients with refractory Takayasu arteritis. The authors have …

I read with great interest the article 'Successful remission with tofacitinib in a patient with
refractory Takayasu arteritis complicated by ulcerative colitis' by Kuwabara et al. 1 In this …

Introduction Takayasu arteritis (TA) is a rare systemic vasculitis that affects large vessels
often resistant to treatment and associated with high morbidity and mortality. Treatment is …